Influence of perinatal factors on thyroid stimulating hormone level in cord blood
Amir-mohammad Armanian1, Mahin Hashemipour2, Azadeh Esnaashari3, Roya Kelishadi4, Ziba Farajzadegan5
1 Department of Neonatologyand, Child Growth and Development Research Center, Isfahan, Iran
2 Department of Pediatric Endocrinology, Child Growth and Development Research Center, Isfahan, Iran
3 Department of Pediatric, Isfahan University of Medical Sciences, Isfahan, Iran
4 Department of Pediatric, Child Growth and Development Research Center, Isfahan, Iran
5 Department of Community Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
|Date of Submission||14-Jun-2012|
|Date of Acceptance||06-Aug-2012|
|Date of Web Publication||29-Jun-2013|
Department of Neonatology, ShahidAnsari Alley-SaebStreet, Isfahan
Source of Support: This project was a residency thesis that performed by
financial support from Vice Chancellery for Research of Isfahan University
of Medical Sciences, Isfahan, Iran (Grant no: 390526),, Conflict of Interest: None
Background: The aim of the present study was to determine the effect of various perinatal factors on cord blood TSH among newborns in Isfahan, Iran.
Materials and Methods: This was a descriptive-analytic cross sectional study which performed in Isfahan Iran. During a period of four months, since February to May 2012 a total number of 440 newborns delivered in Alzahra and Shahid beheshti hospitals were enrolled in the study. For all newborns one mL blood sample from umbilical vein was obtained by one of the project investigators and sent to laboratory for further examinations. Cord blood TSH and birth body weight (BBW), gestational age, history of gestational diabetes mellitus (GDM), apgar at one minute, apgar at five minute, newborn gender and the mother's age were documented. Differences considered statistically significant if P < 0.01.
Results: 440 newborns enrolled in the study, 221 (50.2%) were male and 219 (49.8%) were female. Among study parameters, method of delivery had statistically significant relation with cord blood TSH (P < 0.001), and other factors such as BBW, gestational age, GDM, apgar at one minute, apgar at five minute, newborn gender and the mother's age didn't have statistically significant relationship with cord TSH level.
Conclusion: In conclusion we deduce that the only factor that can affect cord blood TSH was method of delivery. Infant with vaginal delivery has higher TSH level in cord blood. Other factors that were evaluated in this study didn't have any statistically significant relationship.
Keywords: Cord blood, perinatal factors, thyroid stimulating hormone
|How to cite this article:|
Armanian Am, Hashemipour M, Esnaashari A, Kelishadi R, Farajzadegan Z. Influence of perinatal factors on thyroid stimulating hormone level in cord blood. Adv Biomed Res 2013;2:48
|How to cite this URL:|
Armanian Am, Hashemipour M, Esnaashari A, Kelishadi R, Farajzadegan Z. Influence of perinatal factors on thyroid stimulating hormone level in cord blood. Adv Biomed Res [serial online] 2013 [cited 2020 Nov 29];2:48. Available from: https://www.advbiores.net/text.asp?2013/2/1/48/114189
| Introduction|| |
Congenital hypothyroidism (CH) is defined as thyroid hormone deficiency present at birth. Nowadays CH is the most common treatable cause of developmental delay and intellectual disability among new-borns.  Recent reports from different countries have shown an increase in the incidence of CH. The reason is unknown, however, it could be due to advances in screening strategies during last decades.  Recent studies showed the incidence of 1/3000 in western countries.  Asians had higher incidence of approximately 1/1000  and about our provincean incidence of 1/357 in live births is reported.  Owing to high prevalence of CH among newborns all around the world, early detection of CH Seems to be necessary.
Most newborns with congenital hypothyroidism do not present signs and symptoms of thyroid deficiency in early infancy , which is due to passage of maternal thyroid hormones across the placenta  thus it is not possible to predict which infants will be affected. For these reasons, newborn screening was developed in 1970 to detect this condition as early as possible. 
Traditionally screening strategy was based on the collecting Blood for screening on to special paper cards after heel prick, in the first week after delivery,  Recent studies suggest umbilical cord blood sampling as an alternative method for this procedure due to its lower false negative results. ,, Currently in some countries it has been chosen for the methods of choice in the screening program. 
There are previous studies which suggest the relation between some perinatal factors and newborns TSH. For instance a study performed by Franklin et al., mentioned that only birth body weight and method of delivery can affect thyroid hormone indices and other factors such as gestational diabetes do not influence the thyroid stimulating hormone (TSH) level.  On the other hand, the study which was conducted by Herbstman et al., revealed the influence of gestational diabetes and maternal age on thyroid hormone status in infants.  As it is mentioned, although some studies have been performed in this field, however, the result is still controversial. ,,
The aim of the present study was to determine the effect of various perinatal factors on cord TSH level, among newborns in Shahid beheshti and Alzahra Hospital, Isfahan, Iran.
| Materials and Methods|| |
Patients and setting
This was a descriptive-analytic cross sectional study which was performed in Isfahan, Iran. During a period of four months, since February to May 2012, a total number of 440 consecutive newborn delivered in Alzahra and Shahid beheshti hospitals were enrolled in the study. They were excluded if any of the following criteria present: Major congenital malformations, inadequate blood sample, maternal thyroid disease and their mothers refuse to participate in the research projects.
For all the newborns that enrolled in the study, one milliliter blood sample from umbilical vein was obtained by one of the project investigators (AE) and sent to laboratory for further examinations. Complete physical examination has been performed and Apgar score for first and the fifth minute was calculated. Demographic data, gestational age, gestational diabetes and pre-eclampsia were documented in all mothers.
Variables and assessments
TSH measured by Chemi luminescence Immunoassay (CLIA) method and the value of 20 considered as cut off value for CH. 
Gestational age determined by maternal menstrual history. Pre-eclampsia diagnosed by the new onset of hypertension and proteinuria after 20 weeks of gestation in women without history of hypertension.  Gestational diabetes mellitus is defined as impaired glucose tolerance with onset or first recognition during pregnancy.  Apgar score was calculated by one of the research investigators (AE) considering physical examinations for signs such as heart rate, respiratory effort, muscle tone, reflex irritability and Color. 
Data analysis has been performed using SPSS 16 software and comparisons were made using student t-test, ANOVA, Pearson correlation, logistic regression, multiple regression analysis test, as needed. Written Informed consents were obtained from all parents for authorized use of their medical records for research purposes with approval of the protocol by ethical committee of our university.
| Results|| |
A total number of 440 newborns were enrolled in the study, 221 (50.2%) were male and 219 (49.8%) were female. Further descriptive analysis about study variables are shown in [Table 1].
We evaluated the relationships between the categorical variables and cord blood TSH level which shows relationship between method of delivery and TSH level ( P < 0.001). In this study we also have one patient with pre-eclampsia that have a high level of TSH (TSH = 38). Newborns gender does not have any relationship with the cord blood TSH and the difference was not statistically significant between males and females ( P = 0.36). We found five patients with gestational diabetes, the mean cord blood TSH shows no significant difference in the newborns of these patients compared with those, whose mother's pregnancy didn't complicated with gestational diabetes ( P = 0.99). More detailed data are shown in [Table 2].
|Table 2: Relationships between categorical variables and cord blood TSH |
Click here to view
We also evaluated the correlation between quantitative variable of study. None of the parameters including BBW, GA, Apgar one minute, Apgar five minute, and mother's age had statistically significant relationship with TSH. However, some other significant relations between BBW with GA, Apgar one minute, Apgar five minute and another relations between GA with Apgar one minute, Apgar five minute and one other relation between Apgar one minute and Apgar five minute were observed among the variables which were not in the aim of our study. Detailed data are shown in [Table 3].
Linear multivariate logistic regression also were used to confirm the relationship among study variables. Significant relationship was found in method of delivery and cord blood TSH level ( P < 0.001 and β = 0.22). Of 440 newborn that evaluated 22 (5%) found to have cord blood TSH value more than 20, these newborns were recalled for further evaluations.
| Discussion|| |
As we know many perinatal factors during delivery affect TSH, but in our study, only method of delivery had statistically significant relationship with cord blood TSH. Cord blood TSH level was higher in newborns with vaginal delivery compared with the others with cesarean section. The rationale for this condition has not been well established yet; however, it could be explained by stress events during pregnancy and labour. Our findings revealed that the presence of stress factors can results in an elevation in cord blood TSH.
Although some studies have been performed in this field, however, the results are controversial ,,,, and sometimes paradoxical. Fuse et al., performed a study on 124 healthy neonates with different types of delivery, including cesarean section, normal vaginal delivery and by vacuum extractor. They revealed that there was no statistically significant difference in cord blood TSH among neonates in study groups which is in contrast with our study.  Moreover in contrast with our results is the study that performed by Herbstman et al., which evaluated a total number of 300 newborn. Thyroid hormone levels were measured and the association between some perinatal factors was assessed. They revealed that several perinatal factors such as maternal age, pregnancy induced hypertension, gestational diabetes, sexually transmitted disease during pregnancy, alcohol use during pregnancy and Gestational age can affect thyroid hormone status in infants. 
On the other hand, Kim et al., in a project which was held on 130 neonates in Korea showed that cord blood TSH was affected by perinatal stress events and is significantly higher in infants born vaginally than of cesarean section which was in line with our study. 
Although we had a larger sample size compared with previous studies that could cause in significance in lower differences, however, we didn't find statistically significant relations among TSH and other perinatal factors such as GDM, gestational age, apgar at one min, apgar at five min, newborn's gender, BBW and mother's age on the cord blood TSH.
Moreover, we found one patient with pre-eclampsia that showed high level of TSH. This finding is in line with previous studies which evaluated the effect of pre-eclampsia on cord TSH level. They revealed that pre-eclampsia results in elevated TSH level in infants. ,
The strength point of our study was the high sample size compared with previous studies in this field, however, due to low number of pre-eclamptic patients in this study we suggest further studies with higher sample size to evaluate the effect of pre-eclampsia in thyroid hormone level in infants.
In conclusion we deduce that the only factor that can affect cord blood TSH was method of delivery. Infants with vaginal delivery has higher TSH level in cord blood. Other perinatal factors such as BBW, gestational age, GDM, Apgar at one minute, apgar at five minute, newborn's gender and the mother's age don't have statistically significant relationship with cord TSH level.
| References|| |
|1.||Metabolic and endocrine disorders. In: Martin RJ, Fanaroff AA, Walsh MC, editors. Neonatal-Perinatal Medicine. Elsevier, 2011. p. 1497-620. |
|2.||Harris KB, Pass KA. Increase in congenital hypothyroidism in New York State and in the United States. Mol Genet Metab 2007;91:268-77. |
|3.||Shamshiri AR, Yarahmadi S, Forouzanfar MH, Haghdoost AA, Hamzehloo G, Holakouie NK. Evaluation of current guthrie TSH cut-off point in Iran congenital hypothyroidism screening program: A cost-effectiveness analysis. Arch Iran Med 2012;15:136-41. |
|4.||Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis 2010;5:17. |
|5.||Hashemipour M, Hovsepian S, Kelishadi R, Iranpour R, Hadian R, Haghighi S, et al. Permanent and transient congenital hypothyroidism in Isfahan-Iran. J Med Screen 2009;16:11-6. |
|6.||LaFranchi SH. Hypothyroidism. Pediatr Clin North Am 1979;26:33-51. |
|7.||Alm J, Hagenfeldt L, Larsson A, Lundberg K. Incidence of congenital hypothyroidism: Retrospective study of neonatal laboratory screening versus clinical symptoms as indicators leading to diagnosis. Br Med J (Clin Res Ed) 1984;289:1171-5. |
|8.||Vulsma T, Gons MH, de Vijlder JJ. Maternal-fetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect or thyroid agenesis. N Engl J Med 1989;321:13-6. |
|9.||Stephen LaFranchi. Clinical features and detection of congenital hypothyroidism. In: Denise S. Basow, editor. UpToDate. Waltham, MA: UpToDate, 2009. |
|10.||Rose SR, Brown RS, Foley T, Kaplowitz PB, Kaye CI, Sundararajan S, et al. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006;117:2290-303. |
|11.||Narchi HH, Kulaylat NA. Congenital hypothyroidism screening program: A five-year experience at Saudi ARAMCO Al Hasa Health Center. Ann Saudi Med 1996;16:47-9. |
|12.||Henry G, Sobki SH, Othman JM. Screening for congenital hypothyroidism. Saudi Med J 2002;23:529-35. |
|13.||Hardy JD, Zayed R, Doss I, Dhatt GS. Cord blood thyroxine and thyroid stimulating hormone screening for congenital hypothyroidism: How useful are they? J Pediatr Endocrinol Metab 2008;21:245-9. |
|14.||Manglik AK, Chatterjee N, Ghosh G. Umbilical cord blood TSH levels in term neonates: A screening tool for congenital hypothyroidism. Indian Pediatr 2005;42:1029-32. |
|15.||Franklin RC, Carpenter LM, O'Grady CM. Neonatal thyroid function: Influence of perinatal factors. Arch Dis Child 1985;60:141-4. |
|16.||Herbstman J, Apelberg BJ, Witter FR, Panny S, Goldman LR. Maternal, infant, and delivery factors associated with neonatal thyroid hormone status. Thyroid 2008;18:67-76. |
|17.||Miyamoto N, Tsuji M, Imataki T, Nagamachi N, Hirose S, Hamada Y. Influence of mode of delivery on fetal pituitary-thyroid axis. Acta Paediatr Jpn 1991;33:363-8. |
|18.||Fuse Y, Wakae E, Nemoto Y, Uga N, Tanaka M, Maeda M, et al. Influence of perinatal factors and sampling methods on TSH and thyroid hormone levels in cord blood. Endocrinol Jpn 1991;38:297-302. |
|19.||Eun Young kim, Sang Kee Park, Chnag Hun Song, Sung-Chul Lim. Perinatal factors affecting thyroid stimulating hormone (TSH) and thyroid hormone levels in cord blood. Korean journal pediatrics 2005;48:143-7. |
|20.||Revised guidelines for neonatal screening programmes for primary congenital hypothyroidism. Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology. Horm Res 1999;52:49-52. |
|21.||Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi JM. Pre-eclampsia: Pathophysiology, diagnosis, and management. Vasc Health Risk Manag 2011;7:467-74. |
|22.||Farrar D, Duley L, Lawlor DA. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev 2011;CD007122. |
|23.||Juretschke LJ. Apgar scoring: Its use and meaning for today's newborn. Neonatal Netw 2000;19:17-9. |
|24.||Turan S, Bereket A, Angaji M, Koroglu OA, Bilgen H, Onver T, et al. The effect of the mode of delivery on neonatal thyroid function. J Matern Fetal Neonatal Med 2007;20:473-6. |
|25.||Wang Y, Liu R, Guo J. Study on effect of delivery way on thyrotropin levels in pregnant women and their newborns. Zhonghua Fu Chan Ke Za Zhi 2001;36:282-4. |
|26.||Belet N, Imdat H, Yanik F, Kucukoduk S. Thyroid function tests in preterm infants born to preeclamptic mothers with placental insufficiency. J Pediatr Endocrinol Metab 2003;16:1131-5. |
|27.||Chan LY, Chiu PY, Lau TK. Cord blood thyroid-stimulating hormone level in high-risk pregnancies. Eur J Obstet Gynecol Reprod Biol 2003;108:142-5. |
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||Cord blood Thyroid Stimulating Hormone Level - and the influence of perinatal and other factors on it
| ||Poyekar Subhash,Pratinidhi Shilpa,Swapnil S Prasad,Zainab S Sardar,Bhavesh Kankariya,Om Bhole |
| ||Pediatric Oncall. 2019; 16(3) |
|[Pubmed] | [DOI]|
||Perfluoroalkyl and polyfluoroalkyl substances and fetal thyroid hormone levels in umbilical cord blood among newborns by prelabor caesarean delivery
| ||Ruxianguli Aimuzi,Kai Luo,Qian Chen,Hui Wang,Liping Feng,Fengxiu Ouyang,Jun Zhang |
| ||Environment International. 2019; 130: 104929 |
|[Pubmed] | [DOI]|
||Hyperthyroxinemia at birth: a cause of idiopathic neonatal hyperbilirubinemia?
| ||Irena Ulanovsky,Tatiana Smolkin,Shlomo Almashanu,Tatiana Mashiach,Imad R. Makhoul |
| ||World Journal of Pediatrics. 2018; |
|[Pubmed] | [DOI]|
||Cord Blood Thyroid-Stimulating Hormone Level: Interpretation in Light of Antenatal and Perinatal Factors
| ||Ravi Bhatia,Dinesh Rajwaniya,Indira S. Paul |
| ||Journal of Neonatology. 2018; 32(4): 87 |
|[Pubmed] | [DOI]|
||MATERNAL AND PERINATAL FACTORS AFFECTING CORD BLOOD THYROID STIMULATING HORMONE LEVEL
| ||Vinoth Kumar S. P,Peter Pathrose Vazhayil,Indhiradevi Balusamy |
| ||Journal of Evolution of Medical and Dental Sciences. 2018; 7(19): 2415 |
|[Pubmed] | [DOI]|
||Perinatal factors associated with neonatal thyroid-stimulating hormone in normal newborns
| ||Seong Yong Lee |
| ||Annals of Pediatric Endocrinology & Metabolism. 2016; 21(4): 206 |
|[Pubmed] | [DOI]|